MHUA vs. NVNO, MGRM, STIM, APYX, SEPA, LNSR, CTCX, CTSO, ICCM, and LUCD
Should you be buying Meihua International Medical Technologies stock or one of its competitors? The main competitors of Meihua International Medical Technologies include enVVeno Medical (NVNO), Monogram Orthopaedics (MGRM), Neuronetics (STIM), Apyx Medical (APYX), SEP Acquisition (SEPA), LENSAR (LNSR), Carmell (CTCX), Cytosorbents (CTSO), IceCure Medical (ICCM), and Lucid Diagnostics (LUCD). These companies are all part of the "surgical & medical instruments" industry.
Meihua International Medical Technologies (NASDAQ:MHUA) and enVVeno Medical (NASDAQ:NVNO) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their community ranking, media sentiment, risk, institutional ownership, valuation, profitability, dividends, earnings and analyst recommendations.
enVVeno Medical received 156 more outperform votes than Meihua International Medical Technologies when rated by MarketBeat users.
In the previous week, Meihua International Medical Technologies had 1 more articles in the media than enVVeno Medical. MarketBeat recorded 2 mentions for Meihua International Medical Technologies and 1 mentions for enVVeno Medical. enVVeno Medical's average media sentiment score of 1.87 beat Meihua International Medical Technologies' score of 1.44 indicating that enVVeno Medical is being referred to more favorably in the news media.
Meihua International Medical Technologies' return on equity of 0.00% beat enVVeno Medical's return on equity.
Meihua International Medical Technologies has higher revenue and earnings than enVVeno Medical.
1.2% of Meihua International Medical Technologies shares are held by institutional investors. Comparatively, 34.7% of enVVeno Medical shares are held by institutional investors. 66.6% of Meihua International Medical Technologies shares are held by company insiders. Comparatively, 17.0% of enVVeno Medical shares are held by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.
Meihua International Medical Technologies has a beta of 0.4, indicating that its share price is 60% less volatile than the S&P 500. Comparatively, enVVeno Medical has a beta of 1.1, indicating that its share price is 10% more volatile than the S&P 500.
Summary
Meihua International Medical Technologies beats enVVeno Medical on 6 of the 10 factors compared between the two stocks.
Get Meihua International Medical Technologies News Delivered to You Automatically
Sign up to receive the latest news and ratings for MHUA and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding MHUA and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Meihua International Medical Technologies Competitors List
Related Companies and Tools
